Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.

• Váldodahkkit: Catherine E Oldenburg (Dahkki), Ahmed M Arzika (Dahkki), Ramatou Maliki (Dahkki), Mohamed Salissou Kane (Dahkki), Elodie Lebas (Dahkki), Kathryn J Ray (Dahkki), Catherine Cook (Dahkki), Sun Y Cotter (Dahkki), Zhaoxia Zhou (Dahkki), Sheila K West (Dahkki), Robin Bailey (Dahkki), Travis C Porco (Dahkki), Jeremy D Keenan (Dahkki), Thomas M Lietman (Dahkki), MORDOR Study Group (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2018-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BACKGROUND:Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1-5 month olds who received azithromycin as part of a large community-randomized trial...